Owlstone Medical secures $27M in series E funding to advance breath-based diagnostics and commercialization. Led by Ventura ...

CR Pharmaceutical and NAMI collaborate to explore palbociclib’s potential for Alzheimer’s treatment, leveraging ...

US clinical-stage pharma Keros Therapeutics today announced that it has voluntarily halted all dosing in the TROPOS trial, a ...

Boston, USA-based Verastem Oncology today announced the appointment of Matthew Ros as chief operating officer (COO). In his ...

Eli Lilly saw its shares close down 6.6% at $744.91 yesterday, after it revealed forecast for sales at the JP Morgan ...

Cases of avian influenza A (H5N1) continue to rise among cattle and humans in the USA. Scientists and government health ...

Belgian drugmaker UCB has presented what it calls its ‘growth journey’ and the strategic priorities driving future success at ...

Shares of US biotech Regenxbio surged 18.4% in pre-open trading Tuesday after announced a strategic partnership with Japan’s ...

Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a ...

Several of the USA’s biggest pharmacy benefit managers (PBMs) have generated billions of dollars in revenue by charging ...

Japanese drugmaker Daiichi Sankyo announced that it will pay Glycotope GmbH $132.5 million to acquire intellectual property ...

A fully integrated global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer ...